Skip to main content
logo
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1500
0.00 (0.00%)
Sep 18, 2026, 1:55 PM AEST

Argenica Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
5.485.483.212.61.750.26
Revenue Growth
444.85%70.66%23.70%48.46%575.38%-12.49%
Gross Profit
5.485.483.212.61.750.26
Operating Income
-1.58-1.58-7.68-5.67-4.87-4.09
Net Income
-1.37-1.37-7.17-5.48-4.82-4.09
Earnings Per Share
-0.01-0.01-0.06-0.05-0.07-0.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
6.366.3610.5615.919.348.91
Net Cash Growth
26.31%-39.72%-33.67%70.39%4.76%24.78%
Net Cash Per Share
0.050.050.080.150.130.12
Cash & Investments
6.366.3610.5615.919.348.91

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-4.19-4.19-5.7-5.06-3.3-3.36
Free Cash Flow
-4.19-4.19-5.7-5.06-3.3-3.36
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-28.75%-28.75%-239.05%-218.30%-278.59%-1579.49%
Pretax Margin
-24.89%-24.89%-223.11%-210.92%-275.16%-1578.84%
Profit Margin
-24.89%-24.89%-223.12%-210.92%-275.16%-1578.84%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
3.512.2530.3837.2621.08144.26